Moderate levels of cytokine release after DNA transposon-CD19 CAR T-cell infusion could be one of the reasons for mild CRS and ICANS; however, the establishment of a plausible mechanism behind low levels of DNA transposon-CAR T-cell toxicity needs further investigation. This evidence concerns the gene CD19 and congenital rubella syndrome.